होम › ल्यूकेमिया › मेसाचुसेट्स › Boston
Boston, MA में ल्यूकेमिया क्लिनिकल ट्रायल
Boston (लगभग 30 मील के भीतर) की साइटों पर ल्यूकेमिया के लिए 25 अध्ययन प्रतिभागियों की तलाश में हैं। यह देखने के लिए कि कौन शामिल हो सकता है और अध्ययन टीम से कैसे संपर्क करें, एक अध्ययन खोलें।
आधिकारिक अध्ययन पाठ (अंग्रेजी)
यहाँ अध्ययन के लिए भर्ती कर रहे हैं? इसे इस पृष्ठ के शीर्ष पर फीचर करें — 30 दिनों के लिए $99 →
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
भर्ती जारीचरण 2
- Dana-Farber Cancer Institute, Boston
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
भर्ती जारी
- Dana-Farber Cancer Institute, Boston
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
भर्ती जारीचरण 3
- Research Site, Boston
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
भर्ती जारीचरण 2
- Massachusetts General Hospital, Boston
CIML NK Cells With Venetoclax for AML
भर्ती जारीचरण 1
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
भर्ती जारीचरण 1
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
भर्ती जारीचरण 1
- Beth Israel Deaconess Medical Center, Boston
ALL Backbone in AYAs
भर्ती जारीचरण 2
- Dana Farber Cancer Institute, Boston
Addressing Cancer Care Equity With Social Determinants of Health Screening and Early Intervention
भर्ती जारी
- Mass General Brigham Cancer Institute, Boston
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
भर्ती जारीस्वस्थ स्वयंसेवकों का स्वागत है
- Dana-Farber Cancer Institute, Boston
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
भर्ती जारीचरण 1
- Boston Children's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation
भर्ती जारीचरण 1
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
भर्ती जारीचरण 1/2
- Dren Investigational Site, Boston
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
भर्ती जारीचरण 1
- Dana-Farber Cancer Institute, Boston
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
भर्ती जारीअवलोकनात्मक अध्ययन
- Dana-Farber Cancer Institute, Boston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
भर्ती जारीचरण 2/3
- Dana-Farber Cancer Institute, Boston
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
भर्ती जारी
- Massachusetts General Hospital Cancer Center, Boston
Shwachman Diamond Syndrome Registry and Study
भर्ती जारीअवलोकनात्मक अध्ययन
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Revumenib in Combination With 7+3 + Midostaurin in AML
भर्ती जारीचरण 1
- Dana-Farber Cancer Institute, Boston
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
भर्ती जारीचरण 1
- Massachusetts General Hospital, Boston
Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)
भर्ती जारीचरण 1/2
- Dana-Farber Cancer Institute, Boston
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
भर्ती जारीचरण 1/2
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Mosunetuzumab for CLL MRD Clearance
भर्ती जारीचरण 1/2
- Brigham & Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients
भर्ती जारी
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Massachusetts General Hospital Cancer Center, Boston
HEME Home Transfusion Program
भर्ती जारी
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
अन्य शहरों में ल्यूकेमिया ट्रायल
- Houston, TX28 अध्ययन
- New York City, NY19 अध्ययन
- Los Angeles, CA16 अध्ययन
- Chicago, IL16 अध्ययन
- Durham, NC13 अध्ययन
- Baldwin Park, CA12 अध्ययन
- Columbus, OH12 अध्ययन
- Nashville, TN12 अध्ययन
- Philadelphia, PA12 अध्ययन
- Milwaukee, WI11 अध्ययन
- Atlanta, GA11 अध्ययन
- Seattle, WA11 अध्ययन
Boston में अन्य अध्ययन
- स्तन कैंसर111 अध्ययन
- नॉन-स्मॉल सेल लंग कैंसर90 अध्ययन
- कैंसर (सभी प्रकार)86 अध्ययन
- कोलोरैक्टल कैंसर63 अध्ययन
- मेटास्टेटिक कैंसर63 अध्ययन
- फेफड़ों का कैंसर62 अध्ययन
- अंडाशय का कैंसर61 अध्ययन
- प्रोस्टेट कैंसर59 अध्ययन
- अवसाद52 अध्ययन
- एंडोमेट्रियल कैंसर50 अध्ययन
- हृदय अस्वस्थता44 अध्ययन
- तीव्र माइलोइड ल्यूकेमिया44 अध्ययन
ClinicalTrials.gov से, 5 अक्तू॰ 2026 को प्राप्त डेटा। प्रत्येक अध्ययन अपनी योग्यता निर्धारित करता है; अध्ययन टीम तय करती है कि कौन शामिल हो सकता है।